Fabbrini Elisa, Mohammed B Selma, Magkos Faidon, Korenblat Kevin M, Patterson Bruce W, Klein Samuel
Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri, USA.
Gastroenterology. 2008 Feb;134(2):424-31. doi: 10.1053/j.gastro.2007.11.038. Epub 2007 Nov 28.
BACKGROUND & AIMS: Steatosis in patients with nonalcoholic fatty liver disease (NAFLD) is due to an imbalance between intrahepatic triglyceride (IHTG) production and export. The purpose of this study was to evaluate TG metabolism in adipose tissue and liver in NAFLD.
Fatty acid, VLDL-TG, and VLDL-apolipoprotein B-100 (apoB100) kinetics were assessed by using stable isotope tracers in 14 nondiabetic obese subjects with NAFLD (IHTG, 22.7% +/- 2.0%) and 14 nondiabetic obese subjects with normal IHTG content (IHTG, 3.4% +/- 0.4%), matched on age, sex, body mass index, and percent body fat.
Compared with the normal IHTG group, the NAFLD group had greater rates of palmitate release from adipose tissue into plasma (85.4 +/- 6.6 and 114.1 +/- 8.1 micromol/min, respectively; P = .01) and VLDL-TG secretion (11.4 +/- 1.1 and 24.3 +/- 3.1 micromol/min, respectively; P = .001); VLDL-apoB100 secretion rates were not different between groups. The increase in VLDL-TG secretion was primarily due to an increased contribution from "nonsystemic" fatty acids, presumably derived from lipolysis of intrahepatic and intra-abdominal fat and de novo lipogenesis. VLDL-TG secretion rate increased linearly with increasing IHTG content in subjects with normal IHTG but reached a plateau when IHTG content was >/=10% (r = 0.618, P < .001).
Obese persons with NAFLD have marked alterations in both adipose tissue (increased lipolytic rates) and hepatic (increased VLDL-TG secretion) TG metabolism. Fatty acids derived from nonsystemic sources are responsible for the increase in VLDL-TG secretion. However, the increase in hepatic TG export is not adequate to normalize IHTG content.
非酒精性脂肪性肝病(NAFLD)患者的肝脂肪变性是由于肝内甘油三酯(IHTG)生成与输出之间的失衡所致。本研究旨在评估NAFLD患者脂肪组织和肝脏中的甘油三酯(TG)代谢情况。
采用稳定同位素示踪剂,对14名非糖尿病肥胖NAFLD患者(IHTG,22.7%±2.0%)和14名IHTG含量正常的非糖尿病肥胖患者(IHTG,3.4%±0.4%)的脂肪酸、极低密度脂蛋白-TG(VLDL-TG)及极低密度脂蛋白载脂蛋白B-100(apoB100)动力学进行评估,两组在年龄、性别、体重指数及体脂百分比方面相匹配。
与IHTG正常组相比,NAFLD组脂肪组织中棕榈酸释放至血浆的速率更高(分别为85.4±6.6和114.1±8.1μmol/min;P = 0.01),VLDL-TG分泌速率也更高(分别为11.4±1.1和24.3±3.1μmol/min;P = 0.001);两组间VLDL-apoB100分泌速率无差异。VLDL-TG分泌增加主要归因于“非系统性”脂肪酸贡献增加,推测这些脂肪酸源自肝内和腹内脂肪的脂解作用及从头脂肪生成。在IHTG正常的受试者中,VLDL-TG分泌速率随IHTG含量增加呈线性增加,但当IHTG含量≥10%时达到平台期(r = 0.618,P < 0.001)。
患有NAFLD的肥胖者在脂肪组织(脂解速率增加)和肝脏(VLDL-TG分泌增加)的TG代谢方面均有显著改变。非系统性来源的脂肪酸导致了VLDL-TG分泌增加。然而,肝脏TG输出的增加不足以使IHTG含量恢复正常。